BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable ...

Becton, Dickinson (NYSE:BDX) declares $1.04/share quarterly dividend, in line with previous. Forward yield 2.29% Payable Sept. 30; for shareholders of record Sept. 8; ex-div Sept. 8. See BDX Dividend ...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, ...

The selection of BD LibertasTM Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clini ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

TRACTIAL (formerly BD Multimedia), a fintech company listed on Euronext Growth Paris (ALBDM), and the first regulated financial institution in Europe to adopt a structured Bitcoin accumulation ...

Reuters is tracking how companies are responding to the threat posed by <a href=" target="_blank" rel="noopener noreferrer ...

July is thus far shaping up to be a more balanced month with the Dividend Kings collectively seeing a 1.41% gain, through ...

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...

Stevanato has invested significant resources in expanding its operations. Click to read more on STVN's Buy rating and its ...

Brownstein Hyatt Farber Schreck: $18.5 million (versus $16.8 million in Q1 2025 and $17.6 million in Q2 2024) BGR Group: $17.7 million (versus $14.6 million in Q1 2025 and $11.1 million in Q2 2024) ...